These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 23500313)
21. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. Testani JM; Brisco MA; Chen J; McCauley BD; Parikh CR; Tang WH J Am Coll Cardiol; 2013 Aug; 62(6):516-24. PubMed ID: 23747773 [TBL] [Abstract][Full Text] [Related]
22. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Young JB; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; She L; Sun JL; Yancy CW; Fonarow GC; Am J Cardiol; 2008 Jan; 101(2):223-30. PubMed ID: 18178411 [TBL] [Abstract][Full Text] [Related]
23. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060 [TBL] [Abstract][Full Text] [Related]
24. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT. Anand IS; Kuskowski MA; Rector TS; Florea VG; Glazer RD; Hester A; Chiang YT; Aknay N; Maggioni AP; Opasich C; Latini R; Cohn JN Circulation; 2005 Aug; 112(8):1121-7. PubMed ID: 16103233 [TBL] [Abstract][Full Text] [Related]
25. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. Tang WH; Tong W; Jain A; Francis GS; Harris CM; Young JB J Am Coll Cardiol; 2008 Feb; 51(5):569-76. PubMed ID: 18237687 [TBL] [Abstract][Full Text] [Related]
26. Edema index established by a segmental multifrequency bioelectrical impedance analysis provides prognostic value in acute heart failure. Liu MH; Wang CH; Huang YY; Tung TH; Lee CM; Yang NI; Liu PC; Cherng WJ J Cardiovasc Med (Hagerstown); 2012 May; 13(5):299-306. PubMed ID: 22367574 [TBL] [Abstract][Full Text] [Related]
27. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC; J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of new-onset anemia as a marker of hemodilution in patients with acute decompensated heart failure and severe renal dysfunction. Hong N; Youn JC; Oh J; Lee HS; Park S; Choi D; Kang SM J Cardiol; 2014 Jul; 64(1):43-8. PubMed ID: 24368094 [TBL] [Abstract][Full Text] [Related]
29. The interaction between heart failure and other heart diseases, renal failure, and anemia. Silverberg DS; Wexler D; Iaina A; Schwartz D Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468 [TBL] [Abstract][Full Text] [Related]
30. Soluble TNFα receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients. Martínez-Ruiz A; Tornel-Osorio PL; Sánchez-Más J; Pérez-Fornieles J; Vílchez JA; Martínez-Hernández P; Pascual-Figal DA Clin Biochem; 2012 Nov; 45(16-17):1455-8. PubMed ID: 22609894 [TBL] [Abstract][Full Text] [Related]
31. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
32. [Short-term prognosis and treatment of patients hospitalized for acute heart failure in a regional hospital without a cardiocentre]. Zeman K; Pohludková L; Spinar J; Jarkovský J; Littnerová S; Dušek L; Miklík R; Felšöci M; Pařenica J Vnitr Lek; 2012 Apr; 58(4):273-9. PubMed ID: 22559800 [TBL] [Abstract][Full Text] [Related]
33. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. O'Meara E; Clayton T; McEntegart MB; McMurray JJ; Lang CC; Roger SD; Young JB; Solomon SD; Granger CB; Ostergren J; Olofsson B; Michelson EL; Pocock S; Yusuf S; Swedberg K; Pfeffer MA; Circulation; 2006 Feb; 113(7):986-94. PubMed ID: 16476847 [TBL] [Abstract][Full Text] [Related]
34. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data. Metra M; Cotter G; Senger S; Edwards C; Cleland JG; Ponikowski P; Cursack GC; Milo O; Teerlink JR; Givertz MM; O'Connor CM; Dittrich HC; Bloomfield DM; Voors AA; Davison BA Circ Heart Fail; 2018 May; 11(5):e004644. PubMed ID: 29748350 [TBL] [Abstract][Full Text] [Related]
35. Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure. Cioffi G; Tarantini L; Pulignano G; Del Sindaco D; De Feo S; Opasich C; Dilenarda A; Stefenelli C; Furlanello F J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):419-27. PubMed ID: 17502758 [TBL] [Abstract][Full Text] [Related]
36. Baseline anemia is not a predictor of all-cause mortality in outpatients with advanced heart failure or severe renal dysfunction. Results from the Norwegian Heart Failure Registry. Waldum B; Westheim AS; Sandvik L; Flønæs B; Grundtvig M; Gullestad L; Hole T; Os I J Am Coll Cardiol; 2012 Jan; 59(4):371-8. PubMed ID: 22261159 [TBL] [Abstract][Full Text] [Related]
37. Worsening Heart Failure Following Admission for Acute Heart Failure: A Pooled Analysis of the PROTECT and RELAX-AHF Studies. Davison BA; Metra M; Cotter G; Massie BM; Cleland JGF; Dittrich HC; Edwards C; Filippatos G; Givertz MM; Greenberg B; Ponikowski P; Voors AA; O'Connor CM; Teerlink JR; JACC Heart Fail; 2015 May; 3(5):395-403. PubMed ID: 25951761 [TBL] [Abstract][Full Text] [Related]
38. Endogenous erythropoietin and outcome in heart failure. Belonje AM; Voors AA; van der Meer P; van Gilst WH; Jaarsma T; van Veldhuisen DJ Circulation; 2010 Jan; 121(2):245-51. PubMed ID: 20048213 [TBL] [Abstract][Full Text] [Related]
39. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. Ezekowitz JA; Hernandez AF; O'Connor CM; Starling RC; Proulx G; Weiss MH; Bakal JA; Califf RM; McMurray JJ; Armstrong PW J Am Coll Cardiol; 2012 Apr; 59(16):1441-8. PubMed ID: 22497823 [TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of discharge hemoglobin level in patients hospitalized for acute heart failure]. Sánchez-Torrijos J; Gudín-Uriel M; Nadal-Barangé M; Jacas-Osborn V; Trigo-Bautista A; Giménez-Alcalá M; Payá-Serrano R; Ridocci-Soriano F Rev Esp Cardiol; 2006 Dec; 59(12):1276-82. PubMed ID: 17194423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]